Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice

被引:4
作者
Arora, Devinder [1 ,2 ,3 ,4 ]
Mudgal, Jayesh [4 ]
Nampoothiri, Madhavan [4 ]
Mallik, Sanchari Basu [4 ]
Kinra, Manas [4 ]
Hall, Susan [1 ,2 ,3 ]
Anoopkumar-Dukie, Shailendra [1 ,2 ,3 ]
Grant, Gary D. [1 ,2 ,3 ]
Rao, Chamallamudi Mallikarjuna [4 ]
机构
[1] Griffith Univ, Sch Pharm & Pharmacol, Gold Coast, Qld 4222, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
[3] Griffith Univ, Qual Use Med Network, Gold Coast, Qld, Australia
[4] Manipal Acad Higher Educ, Dept Pharmacol, Manipal Coll Pharmaceut Sci, Manipal 576104, Karnataka, India
关键词
Extrapyramidal side effects; Akinesia; Catalepsy; Caffeine; Naproxen; PARKINSONS-DISEASE; POSSIBLE INVOLVEMENT; CATALEPTIC BEHAVIOR; DOPAMINE; CAFFEINE; PATHWAYS; AGONIST; COFFEE; PROSTAGLANDINS; ACTIVATION;
D O I
10.1007/s11011-018-0201-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antipsychotic drugs are the mainstay of psychotic disorders. The 'typical' antipsychotic agents are commonly employed for the positive symptoms of schizophrenia, though at an expense of extrapyramidal side effects (EPS). In the present study, we employed haloperidol (HP)-induced catalepsy model in mice to evaluate the role of adenosine receptor antagonist and cyclooxygenase (COX) enzyme inhibitor in the amelioration of EPS. HP produced a full blown catalepsy, akinesia and a significant impairment in locomotion and antioxidant status. Pre-treatment with COX inhibitor; naproxen (NPx) and adenosine receptor antagonist; caffeine (CAF), showed a significant impact on HP-induced cataleptic symptoms. Adenosine exerts pivotal control on dopaminergic receptors and is also involved in receptor internalization and recycling. On the other hand, prostaglandins (PGs) are implicated as neuro-inflammatory molecules released due to microglial activation in both Parkinson's disease (PD) and antipsychotics-induced EPS. The involvement of these neuroeffector molecules has led to the possibility of use of CAF and COX inhibitors as therapeutic approaches to reduce the EPS burden of antipsychotic drugs. Both these pathways seem to be interlinked to each other, where adenosine modulates the formation of PGs through transcriptional modulation of COXs. We observed an additive effect with combined treatment of NPx and CAF against HP-induced movement disorder. These effects lead us to propose that neuromodulatory pathways of dopaminergic circuitry need to be explored for further understanding and utilizing the full therapeutic potential of antipsychotic agents.
引用
收藏
页码:1045 / 1051
页数:7
相关论文
共 53 条
[1]   Targeting cyclooxygenases-1 and-2 in neuroinflammation: Therapeutic implications [J].
Aid, Saba ;
Bosetti, Francesca .
BIOCHIMIE, 2011, 93 (01) :46-51
[2]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[3]   DOPAMINE AND THE PATHO-PHYSIOLOGY OF DYSKINESIAS INDUCED BY ANTIPSYCHOTIC-DRUGS [J].
BALDESSARINI, RJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1980, 3 :23-41
[4]   Dopamine responsiveness is regulated by targeted sorting of D2 receptors [J].
Bartlett, SE ;
Enquist, J ;
Hopf, FW ;
Lee, JH ;
Gladher, F ;
Kharazia, V ;
Waldhoer, M ;
Mailliard, WS ;
Armstrong, R ;
Bonci, A ;
Whistler, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (32) :11521-11526
[5]   On the Existence of a Possible A2A-D2-β-Arrestin2 Complex: A2A Agonist Modulation of D2 Agonist-Induced β-Arrestin2 Recruitment [J].
Borroto-Escuela, Dasiel O. ;
Romero-Fernandez, Wilber ;
Tarakanov, Alexander O. ;
Ciruela, Francisco ;
Agnati, Luigi F. ;
Fuxe, Kjell .
JOURNAL OF MOLECULAR BIOLOGY, 2011, 406 (05) :687-699
[6]   Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease [J].
Chen, JF ;
Xu, K ;
Petzer, JP ;
Staal, R ;
Xu, YH ;
Beilstein, M ;
Sonsalla, PK ;
Castagnoli, K ;
Castagnoli, N ;
Schwarzschild, MA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (10) :art. no.-RC143
[7]  
COSTALL B, 1973, ARZNEIMITTEL-FORSCH, V23, P674
[8]   Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases [J].
de Assis Lima, Isabel Vieira ;
Silva Bastos, Leandro Francisco ;
Limborco-Filho, Marcelo ;
Fiebich, Bernd L. ;
Pinheiro de Oliveira, Antonio Carlos .
MEDIATORS OF INFLAMMATION, 2012, 2012
[9]   Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [J].
Dold, Markus ;
Samara, Myrto T. ;
Li, Chunbo ;
Tardy, Magdolna ;
Leucht, Stefan .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01)
[10]  
El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170